Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion

Seung Hwa Lee; Jeong Hoon Yang; Seung-Hyuk Choi; Taek Kyu Park; Woo Jin Jang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Hyeon-Cheol Gwon

doi:10.1371/journal.pone.0176737

Loading metrics

Open Access

Peer-reviewed

Research Article

Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion

Seung Hwa Lee ,

Contributed equally to this work with: Seung Hwa Lee, Jeong Hoon Yang

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
⨯
Jeong Hoon Yang ,

Contributed equally to this work with: Seung Hwa Lee, Jeong Hoon Yang

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
⨯
Seung-Hyuk Choi ,

* E-mail: sh1214.choi@samsung.com

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

http://orcid.org/0000-0002-0304-6317

⨯
Taek Kyu Park,

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
⨯
Woo Jin Jang,

Affiliation Division of Cardiology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
⨯
Young Bin Song,

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
⨯
Joo-Yong Hahn,

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
⨯
Jin-Ho Choi,

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
⨯
Hyeon-Cheol Gwon

Affiliation Division of Cardiology, Department of Medicine, Heart, Stroke and Vascular Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
⨯

Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion

Seung Hwa Lee,
Jeong Hoon Yang,
Seung-Hyuk Choi,
Taek Kyu Park,
Woo Jin Jang,
Young Bin Song,
Joo-Yong Hahn,
Jin-Ho Choi,
Hyeon-Cheol Gwon

Published: May 5, 2017
https://doi.org/10.1371/journal.pone.0176737

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Antiplatelet therapy
Is the Subject Area "Antiplatelet therapy" applicable to this article?

Thanks for your feedback.
Hemorrhage
Is the Subject Area "Hemorrhage" applicable to this article?

Thanks for your feedback.
Coronary stenting
Is the Subject Area "Coronary stenting" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Coronary angioplasty
Is the Subject Area "Coronary angioplasty" applicable to this article?

Thanks for your feedback.
Thrombosis
Is the Subject Area "Thrombosis" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Coronary heart disease
Is the Subject Area "Coronary heart disease" applicable to this article?

Thanks for your feedback.